[{"Assets_0_Q1_USD":494226000.0,"CommonStockSharesOutstanding_0_Q1_shares":27006293.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-16099000.0,"NetIncomeLoss_1_Q1_USD":-22078000.0,"StockholdersEquity_0_Q1_USD":468155000.0,"Ticker":"ANAB","CIK":"1370053","name":"ANAPTYSBIO INC","OfficialName":"AnaptysBio Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"617648593.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190507"}]